Attached files
file | filename |
---|---|
EX-3.1 - EXHIBIT 3.1 - Midas Medici Group Holdings, Inc. | ex31.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest reported): June 10, 2011
Midas Medici Group Holdings, Inc.
(Exact name of registrant as specified in its charter)
Delaware | 000-52621 | 37-1532843 |
(State or other jurisdiction | Commission | (IRS Employer |
of incorporation) | file number | Identification No.) |
445 Park Avenue, 20th Floor, New York, New York 10222
Registrant’s telephone number, including area code (212) 792-0920
Copies to:
Thomas Rose, Esq.
Marcelle S. Balcombe, Esq.
Sichenzia Ross Friedman Ference LLP
61 Broadway, 32 nd Floor
New York, New York 10006
Phone: (212) 930-9700
Fax: (212) 930-9725
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
/_/ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
/_/ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
/_/ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
/_/ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
1
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
On June 10, 2011, our board of directors approved an amendment to Section 1 of Article V of our By-laws to allow us to issue shares of common stock in uncertificated form. A copy of the amendment is attached hereto as Exhibit 3.1 and is incorporated herein in its entirety by reference.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
|
Exhibit Number
|
Description
|
|
3.1
|
Amendment to By-Laws
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Midas Medici Group Holdings, Inc.
|
|||
Date: June 16, 2011
|
By:
|
/s/ Nana Baffour | |
Nana Baffour, CEO and
|
|||
Co-Executive Chairman
|
|||
2